AnaptysBio, Inc (NASDAQ:ANAB) Given Average Recommendation of Hold by Brokerages theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
AnaptysBio, Inc. (NASDAQ:ANAB – Get Free Report) was the target of a large increase in short interest during the month of January. As of January 31st, there was short interest totalling 5,110,000 shares, an increase of 13.1% from the January 15th total of 4,520,000 shares. Currently, 22.2% of the company’s stock are sold short. Based […]
AnaptysBio, Inc. (NASDAQ:ANAB – Get Free Report) CFO Dennis Mulroy sold 2,180 shares of the business’s stock in a transaction dated Monday, January 8th. The shares were sold at an average price of $21.81, for a total transaction of $47,545.80. Following the transaction, the chief financial officer now directly owns 4,029 shares of the company’s […]
SAN DIEGO, Sept. 12, 2022 AnaptysBio, Inc. , a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that the company has sold its. | September 12, 2022